Three commonly predicted targets of the miR-17/92 cluster showing anti-correlated expression are tumor suppressors TGFBR2 [46], DCN [47], and CAV1 [48] which were under-expressed in the breast tumor tissues. The gene discussed is TGFBR2; the disease is breast neoplasm.